The Quinazoline Derivative, <scp>QNZ</scp>, Alleviates Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells
Quinazoline derivative QNZ could suppress neuroinflammation, alleviate the progression of EAE and be associated with reduced Th1 and Th17 immunity.
Authors
- Yuan Yang (ORCID: https://orcid.org/0000-0002-8364-3671)
- Xingyan Luo (ORCID: https://orcid.org/0000-0002-7478-1984)
- Ying Xin Xu (ORCID: https://orcid.org/0000-0001-9570-8666)
- Yantang Wang (ORCID: https://orcid.org/0000-0003-0854-4988)
- Juan Li
- Yan Zhou (ORCID: https://orcid.org/0000-0002-8796-0797)
- Fan Yang (ORCID: https://orcid.org/0000-0001-7736-1873)
- Yang Liu (ORCID: https://orcid.org/0000-0002-9442-700X)
- Shan Chen (ORCID: https://orcid.org/0000-0002-1364-4265)
- Yuhang Kong
- Gan Zhang
Institutions
- Chengdu Medical College (CN)
- Sichuan University (CN)
- West China Second University Hospital of Sichuan University (CN)
- First Affiliated Hospital of Chengdu Medical College (CN)
Publication Details
- Journal
- CNS Neuroscience & Therapeutics
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1111/cns.70555
- Citations
- 2
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- Chengdu Medical College
- National Natural Science Foundation of China
- Natural Science Foundation of Sichuan Province